share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 20 23:58
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired by Altshuler on 02/17/2024, through restricted stock vesting and performance shares, both as part of compensation from the issuer. This transaction follows a previous sale of 3,145 shares by Altshuler on 02/12/2024, which grossed $1,321,654.80. The notice for the upcoming sale was filed on the same day as the planned sale, with the plan for this transaction having been adopted on 05/10/2023.
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired by Altshuler on 02/17/2024, through restricted stock vesting and performance shares, both as part of compensation from the issuer. This transaction follows a previous sale of 3,145 shares by Altshuler on 02/12/2024, which grossed $1,321,654.80. The notice for the upcoming sale was filed on the same day as the planned sale, with the plan for this transaction having been adopted on 05/10/2023.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.